Effect of Sesame Oil in Preventing Phlebitis

Sponsor
Cukurova University (Other)
Overall Status
Completed
CT.gov ID
NCT05326568
Collaborator
(none)
44
1
2
30
44.6

Study Details

Study Description

Brief Summary

Background: To determine the effect of sesame oil in preventing phlebitis that may occur during intravenous therapy in patients undergoing cardiac surgery.

Material and Method: A randomized controlled interventional study will be conducted with patients treated in the coronary intensive care unit of a university hospital. The population of the study will be the patients hospitalized in the intensive care unit after cardiac surgery and administered parenteral amiodarone infusion. The power analysis was carried out by taking the study by. The sample size was determined as 44 patients. Personal Information Form and Visual Infusion Phlebitis Scale will be used to collect data. Sesame oil will be applied to the patients in the intervention group as 10 drops, 10 cm around the cannula, for 10 minutes. This administration will be repeated every eight hours during the 24-hour amiodarone infusion. No application will be made by the researcher to the patients in the control group. At the end of each 24 hours, patients in both groups will be evaluated by the investigator on the Visual Infusion Phlebitis Scale. Descriptive statistics, chi square, independent t test and Fisher's exact test will be used to evaluate the data.

Condition or Disease Intervention/Treatment Phase
  • Other: Complementary treatment practice
N/A

Detailed Description

No application was made to the patients assigned to the control group. Sesame oil was applied by the researcher to the patients assigned to the intervention group. Sesame oil was applied to the 10 cm circumference of the cannula by applying 10 drops and 10 minutes. This application was repeated every eight hours during the 24-hour amiodarone infusion. The area where the intravenous line is located is covered with a standard transparent dressing (Tegaderm) so that it can be observed. Patients in the intervention and control groups were evaluated for phlebitis at the end of every 24 hours (1st day, 2nd day, 3rd day) according to the VIP scale. The highest of the phlebitis stages obtained as a result of the evaluation was accepted as the final evaluation.

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective, parallel, two-arm randomized controlled clinical trialProspective, parallel, two-arm randomized controlled clinical trial
Masking:
Single (Outcomes Assessor)
Masking Description:
After the research report is written, a third person will assign an intervention and control group to the letters.
Primary Purpose:
Other
Official Title:
The Effect of Sesame Oil on the Prevention of Phlebitis in Patients Undergoing Cardiac Surgery
Actual Study Start Date :
Apr 15, 2022
Actual Primary Completion Date :
May 15, 2022
Actual Study Completion Date :
May 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

Sesame oil was applied by the researcher to the patients assigned to the intervention group. Sesame oil was applied to the 10 cm circumference of the cannula, in the form of 10 drops and 10 minutes.

Other: Complementary treatment practice
Applying sesame oil to the patients assigned to the intervention group by applying 10 drops to the 10 cm circumference of the cannula for 10 minutes

No Intervention: Control

No treatment was applied to the patients assigned to the control group and only standard care was applied.

Outcome Measures

Primary Outcome Measures

  1. Visual Infusion Phlebitis Scale [Change from 1st day to 2nd day, and 3rd day after the implementation]

    The scale monitors the potential risks of the catheter when administering peripheral venous therapy and rates the developmental stages of phlebitis. Scores range from 0-4. A score of zero indicates that there are no signs of phlebitis, and a score of four indicates that the phlebitis is in the last stage.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients who had undergone cardiac surgery,

  • were over 18 years old,

  • were conscious, could communicate,

  • were not allergic to sesame,

  • were administered prophylactic rhythm regulator

  • amiodarone as a treatment were included in the study.

Exclusion Criteria:
  • who was with cancer,

  • who was with diabetes mellitus,

  • who was with hypertension

  • who was with peripheral vascular disease

  • Patients who had myocardial infarction during the procedure,

  • Received immunosuppressive therapy,

  • underwent resuscitation and could not use an intravenous catheter for any reason

Contacts and Locations

Locations

Site City State Country Postal Code
1 Muaz GÜLŞEN Adana Turkey 01250

Sponsors and Collaborators

  • Cukurova University

Investigators

  • Study Director: Sevban ARSLAN, PhD, Cukurova University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Muaz Gulsen, Academic Lecturer, Cukurova University
ClinicalTrials.gov Identifier:
NCT05326568
Other Study ID Numbers:
  • CukurovaUnıversıty-Mgulsen-01
First Posted:
Apr 13, 2022
Last Update Posted:
Jul 22, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Muaz Gulsen, Academic Lecturer, Cukurova University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2022